Inovio Pharmaceuticals, Inc.INONASDAQ
LOADING
|||
EPS Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
35.14%
↑ 137% above average
Average (9y)
-94.39%
Historical baseline
Range
High:56.72%
Low:-890.85%
CAGR
+2.0%
Modest growth trend
| Period | Value |
|---|---|
| 2024 | 35.14% |
| 2023 | 56.72% |
| 2022 | -890.85% |
| 2021 | -32.71% |
| 2020 | -10.31% |
| 2019 | 7.62% |
| 2018 | 2.78% |
| 2017 | -6.93% |
| 2016 | -134.88% |
| 2015 | 29.51% |